Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2022-02-11
6:04 pm
Unchanged		13GAcutus Medical, Inc.
AFIB		Advent Life Sciences LLP1,619,371
5.8%		0
(Unchanged)		View
2022-02-11
5:59 pm
Purchase		13GAura Biosciences, Inc.
AURA		Advent Life Sciences LLP2,023,857
6.9%		2,023,857increase
(New Position)		View
2021-04-13
2:05 pm
Purchase		13DEloxx Pharmaceuticals, Inc.
ELOX		Advent Life Sciences LLP2,532,270
6.3%		2,532,270increase
(New Position)		View
2021-02-10
3:46 pm
Purchase		13GAcutus Medical, Inc.
AFIB		Advent Life Sciences LLP1,619,371
5.8%		1,619,371increase
(New Position)		View
2021-02-10
3:40 pm
Purchase		13DIterum Therapeutics plc
ITRM		Advent Life Sciences LLP2,890,085
3.5%		2,010,683increase
(+228.64%)		View
2020-02-11
1:57 pm
Sale		13GAxonics, Inc.
AXNX		Advent Life Sciences LLP1,273,859
3.7%		-422,990decrease
(-24.93%)		View
2020-01-29
4:39 pm
Purchase		13DIterum Therapeutics plc
ITRM		Advent Life Sciences LLP879,402
5.9%		11,241increase
(+1.29%)		View
2019-02-11
3:50 pm
Purchase		13GAxonics, Inc.
AXNX		Advent Life Sciences LLP1,696,849
6.1%		1,696,849increase
(New Position)		View
2018-06-08
5:40 pm
Purchase		13DIterum Therapeutics plc
ITRM		Advent Life Sciences LLP868,161
6.2%		868,161increase
(New Position)		View